Emil Chuang
Independent DirectorDr. Emil Chuang, M.B.B.S. FRACP, MD, has served as Chief Medical Officer at Intrinsic Medicine, Inc. since September 2021. Dr. Chuang has worked as consultant for Chuang Global Consulting, providing consulting services to companies in the life science industry since August 2016. Prior to joining Intrinsic Medicine, Dr. Chuang served as Vice President, Precision Medicine for Progenity, Inc., a biotechnology company developing molecular testing products and novel therapeutics, from July 2018 until December 2020, where he led the Clinical Translational and Clinical Operations departments and was also an Officer of the company. Prior to that he served as Global Head of Translational Research and Early Clinical, Gastroenterology for Takeda Pharmaceuticals, a global biopharmaceutical company, from October 2016 until June 2018, where he was responsible for advancing early clinical assets to proof-of-concept stage of development. Dr. Chuang has served in numerous other leadership roles, including as Head of GI Clinical Development and Medical Affairs at Prometheus, where he worked on diagnostic and therapeutic products for patients with IBS and IBD. He joined Nestle Health Science in Switzerland following its acquisition of Prometheus in 2012, where for almost four years he helped develop Nestle’s strategy to bridge medical foods with therapeutics to deliver safer and efficacious products and was responsible for filing the first IND ever for a medical food. Dr. Chuang is a pediatric gastroenterologist and completed his GI and Nutrition training at Children’s Hospital of Philadelphia. He is Director of Palisade Bio, Inc. since July 7, 2025. He then joined the faculty at Duke University and the University of Pennsylvania before transitioning to the pharmaceuticals industry. He has authored over 70 peer-reviewed publications, abstracts and book chapters. Dr. Chuang received his medical degree at the University of Sydney and completed his pediatric specialty training in Australia before moving to the United States.
Positions
- Company NamePalisade Bio, Inc.Stock CodePALIPositionIndependent DirectorColleagues
- JDJ. D. FinleyCEO, CFO & Director
- DADonald A. WilliamsIndependent Chairman of the Board
- MLMitchell Lawrence JonesPresident & Chief Medical Officer
- RCRamesh C. DonthamsettyHead of IR and Corporate Strategy
- JEJulien E. CapersGeneral Counsel & Corporate Secretary
- JHJoerg HeyerHead of Translational Science & Medicine
- BWBinxian WeiIndependent Director
- BEBruce E. SandsMember of Clinical Advisory Board
